+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Gastrointestinal OTC Drugs Market 2023-2027

  • PDF Icon

    Report

  • 177 Pages
  • May 2023
  • Region: Global
  • TechNavio
  • ID: 5821258
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The gastrointestinal OTC drugs market is forecasted to grow by USD 4759.86 mn during 2022-2027, accelerating at a CAGR of 5.29% during the forecast period. The report on the gastrointestinal OTC drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of gastrointestinal disorders, a rise in adoption of gastrointestinal OTC drugs due to easy availability and affordability, and the availability of multiple payment options.

The gastrointestinal OTC drugs market is segmented as below:

By Product

  • Antacid
  • Laxatives
  • Anti-diarrheal
  • Anti-emetics
  • Others

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in the adoption of online platforms for gastrointestinal OTC drugs as one of the prime reasons driving the gastrointestinal OTC drugs market growth during the next few years. Also, an increase in the number of drug approvals and a shift by pharmaceutical companies from prescription to gastrointestinal OTC drugs will lead to sizable demand in the market.

The report on the gastrointestinal OTC drugs market covers the following areas:

  • Gastrointestinal OTC drugs market sizing
  • Gastrointestinal OTC drugs market forecast
  • Gastrointestinal OTC drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal OTC drugs market vendors that include Abbott Laboratories, AbbVie Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., Zoic Pharmaceuticals Pvt. Ltd., and Boehringer Ingelheim International GmbH. Also, the gastrointestinal otc drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global gastrointestinal OTC drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global gastrointestinal otc drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antacid - Market size and forecast 2022-2027
Exhibit 34: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
6.4 Laxatives - Market size and forecast 2022-2027
Exhibit 38: Chart on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Laxatives - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Laxatives - Year-over-year growth 2022-2027 (%)
6.5 Anti-diarrheal - Market size and forecast 2022-2027
Exhibit 42: Chart on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
6.6 Anti-emetics - Market size and forecast 2022-2027
Exhibit 46: Chart on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Anti-emetics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Anti-emetics - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 58: Chart on Comparison by Distribution Channel
Exhibit 59: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 124: AbbVie Inc. - Overview
Exhibit 125: AbbVie Inc. - Product / Service
Exhibit 126: AbbVie Inc. - Key news
Exhibit 127: AbbVie Inc. - Key offerings
12.5 Bausch Health Co. Inc.
Exhibit 128: Bausch Health Co. Inc. - Overview
Exhibit 129: Bausch Health Co. Inc. - Business segments
Exhibit 130: Bausch Health Co. Inc. - Key news
Exhibit 131: Bausch Health Co. Inc. - Key offerings
Exhibit 132: Bausch Health Co. Inc. - Segment focus
12.6 Bayer AG
Exhibit 133: Bayer AG - Overview
Exhibit 134: Bayer AG - Business segments
Exhibit 135: Bayer AG - Key news
Exhibit 136: Bayer AG - Key offerings
Exhibit 137: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 138: Boehringer Ingelheim International GmbH - Overview
Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
Exhibit 140: Boehringer Ingelheim International GmbH - Key news
Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
12.8 Cipla Ltd.
Exhibit 143: Cipla Ltd. - Overview
Exhibit 144: Cipla Ltd. - Business segments
Exhibit 145: Cipla Ltd. - Key news
Exhibit 146: Cipla Ltd. - Key offerings
Exhibit 147: Cipla Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus
12.10 GlaxoSmithKline Plc
Exhibit 152: GlaxoSmithKline Plc - Overview
Exhibit 153: GlaxoSmithKline Plc - Business segments
Exhibit 154: GlaxoSmithKline Plc - Key news
Exhibit 155: GlaxoSmithKline Plc - Key offerings
Exhibit 156: GlaxoSmithKline Plc - Segment focus
12.11 Haleon Plc
Exhibit 157: Haleon Plc - Overview
Exhibit 158: Haleon Plc - Business segments
Exhibit 159: Haleon Plc - Key offerings
Exhibit 160: Haleon Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Exhibit 161: Johnson and Johnson Services Inc. - Overview
Exhibit 162: Johnson and Johnson Services Inc. - Business segments
Exhibit 163: Johnson and Johnson Services Inc. - Key news
Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
12.13 Novartis AG
Exhibit 166: Novartis AG - Overview
Exhibit 167: Novartis AG - Business segments
Exhibit 168: Novartis AG - Key offerings
Exhibit 169: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
12.15 Prestige Consumer Healthcare Inc.
Exhibit 174: Prestige Consumer Healthcare Inc. - Overview
Exhibit 175: Prestige Consumer Healthcare Inc. - Business segments
Exhibit 176: Prestige Consumer Healthcare Inc. - Key offerings
Exhibit 177: Prestige Consumer Healthcare Inc. - Segment focus
12.16 Sanofi SA
Exhibit 178: Sanofi SA - Overview
Exhibit 179: Sanofi SA - Business segments
Exhibit 180: Sanofi SA - Key news
Exhibit 181: Sanofi SA - Key offerings
Exhibit 182: Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 184: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 185: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 186: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 187: Inclusions checklist
Exhibit 188: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 189: Currency conversion rates for US$
13.4 Research methodology
Exhibit 190: Research methodology
Exhibit 191: Validation techniques employed for market sizing
Exhibit 192: Information sources
13.5 List of abbreviations
Exhibit 193: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global gastrointestinal otc drugs market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Laxatives - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Laxatives - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Anti-emetics - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Anti-emetics - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by Distribution Channel
Exhibits 59: Data Table on Comparison by Distribution Channel
Exhibits 60: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 68: Market opportunity by Distribution Channel ($ million)
Exhibits 69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2022 and 2027
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Abbott Laboratories - Overview
Exhibits 120: Abbott Laboratories - Business segments
Exhibits 121: Abbott Laboratories - Key news
Exhibits 122: Abbott Laboratories - Key offerings
Exhibits 123: Abbott Laboratories - Segment focus
Exhibits 124: AbbVie Inc. - Overview
Exhibits 125: AbbVie Inc. - Product / Service
Exhibits 126: AbbVie Inc. - Key news
Exhibits 127: AbbVie Inc. - Key offerings
Exhibits 128: Bausch Health Co. Inc. - Overview
Exhibits 129: Bausch Health Co. Inc. - Business segments
Exhibits 130: Bausch Health Co. Inc. - Key news
Exhibits 131: Bausch Health Co. Inc. - Key offerings
Exhibits 132: Bausch Health Co. Inc. - Segment focus
Exhibits 133: Bayer AG - Overview
Exhibits 134: Bayer AG - Business segments
Exhibits 135: Bayer AG - Key news
Exhibits 136: Bayer AG - Key offerings
Exhibits 137: Bayer AG - Segment focus
Exhibits 138: Boehringer Ingelheim International GmbH - Overview
Exhibits 139: Boehringer Ingelheim International GmbH - Business segments
Exhibits 140: Boehringer Ingelheim International GmbH - Key news
Exhibits 141: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 142: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 143: Cipla Ltd. - Overview
Exhibits 144: Cipla Ltd. - Business segments
Exhibits 145: Cipla Ltd. - Key news
Exhibits 146: Cipla Ltd. - Key offerings
Exhibits 147: Cipla Ltd. - Segment focus
Exhibits 148: Dr Reddys Laboratories Ltd. - Overview
Exhibits 149: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 151: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 152: GlaxoSmithKline Plc - Overview
Exhibits 153: GlaxoSmithKline Plc - Business segments
Exhibits 154: GlaxoSmithKline Plc - Key news
Exhibits 155: GlaxoSmithKline Plc - Key offerings
Exhibits 156: GlaxoSmithKline Plc - Segment focus
Exhibits 157: Haleon Plc - Overview
Exhibits 158: Haleon Plc - Business segments
Exhibits 159: Haleon Plc - Key offerings
Exhibits 160: Haleon Plc - Segment focus
Exhibits 161: Johnson and Johnson Services Inc. - Overview
Exhibits 162: Johnson and Johnson Services Inc. - Business segments
Exhibits 163: Johnson and Johnson Services Inc. - Key news
Exhibits 164: Johnson and Johnson Services Inc. - Key offerings
Exhibits 165: Johnson and Johnson Services Inc. - Segment focus
Exhibits 166: Novartis AG - Overview
Exhibits 167: Novartis AG - Business segments
Exhibits 168: Novartis AG - Key offerings
Exhibits 169: Novartis AG - Segment focus
Exhibits 170: Pfizer Inc. - Overview
Exhibits 171: Pfizer Inc. - Product / Service
Exhibits 172: Pfizer Inc. - Key news
Exhibits 173: Pfizer Inc. - Key offerings
Exhibits 174: Prestige Consumer Healthcare Inc. - Overview
Exhibits 175: Prestige Consumer Healthcare Inc. - Business segments
Exhibits 176: Prestige Consumer Healthcare Inc. - Key offerings
Exhibits 177: Prestige Consumer Healthcare Inc. - Segment focus
Exhibits 178: Sanofi SA - Overview
Exhibits 179: Sanofi SA - Business segments
Exhibits 180: Sanofi SA - Key news
Exhibits 181: Sanofi SA - Key offerings
Exhibits 182: Sanofi SA - Segment focus
Exhibits 183: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 184: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 185: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 186: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 187: Inclusions checklist
Exhibits 188: Exclusions checklist
Exhibits 189: Currency conversion rates for US$
Exhibits 190: Research methodology
Exhibits 191: Validation techniques employed for market sizing
Exhibits 192: Information sources
Exhibits 193: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global gastrointestinal OTC drugs market: Abbott Laboratories, AbbVie Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., Zoic Pharmaceuticals Pvt. Ltd., and Boehringer Ingelheim International GmbH.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is an increase in adoption of online platforms for gastrointestinal OTC drugs.'

According to the report, one of the major drivers for this market is the increase in the prevalence of gastrointestinal disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch Health Co. Inc.
  • Bayer AG
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Haleon Plc
  • Johnson and Johnson Services Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Phathom Pharmaceuticals Inc.
  • Prestige Consumer Healthcare Inc.
  • Sanofi SA
  • SonoScape Medical Corp.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Vee Excel Drugs And Pharmaceuticals Pvt. Ltd.
  • Zoic Pharmaceuticals Pvt. Ltd.
  • Boehringer Ingelheim International GmbH

Related Topics

Related Reports

Over The Counter Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Over The Counter Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 143 Pages
  • Global
From
Over the Counter (OTC) Drugs - Global Strategic Business Report - Product Image

Over the Counter (OTC) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Gastrointestinal Diseases Therapeutics Market 2023-2027 - Product Image

Global Gastrointestinal Diseases Therapeutics Market 2023-2027

  • Report
  • 168 Pages
  • Global
From
Global Nicotine Gum Market 2023-2027 - Product Image

Global Nicotine Gum Market 2023-2027

  • Report
  • 163 Pages
  • Global
From
Global Digestive Remedies Market: Analysis By Type, By Formulation, By Distribution Channel, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Image

Global Digestive Remedies Market: Analysis By Type, By Formulation, By Distribution Channel, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • 168 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.